BioXcel Therapeutics (BTAI) Ends The Year On High Note, Stock Up Over 300%

Shares of BioXcel Therapeutics Inc. (BTAI) closed Tuesday, the last trading day of 2019, at $14.61, up a whopping 338% in the year.

from RTT - Biotech https://ift.tt/35joUAx
via IFTTT

Activity May Be Subdued On Final Trading Day Of 2019

The major U.S. index futures are currently pointing to a roughly flat open on Tuesday following the pullback seen in the previous session.

from RTT - Market Analysis https://ift.tt/2QbbtOE
via IFTTT

Universal Music sells stake to Chinese giant Tencent

Owner Vivendi to offload 10% stake worth €3bn with more deals likely to cash in on music revival

Universal Music Group, the home of stars including Taylor Swift, Lady Gaga and The Beatles, has sold a 10% stake to a consortium led by Chinese tech giant Tencent in a deal valuing the world’s largest music company at €30bn (€25bn).

UMG’s parent company, Vivendi, which is controlled by the French billionaire Vincent Bolloré, has also agreed that the Tencent-led consortium has the option to buy another stake of up to 10% at the same price by 15 January 2021.

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/2QbHAxt

EyeGate Pharma (EYEG) Has Caught Investors' Eyes, Stock Up 300% In 3 Months

Shares of EyeGate Pharmaceuticals Inc. (EYEG), which closed at a new 52-week high of $12.20 on Monday, have gained an impressive 312% in the last three months.

from RTT - Biotech https://ift.tt/35bgIC3
via IFTTT

ERYTECH Pharma (ERYP) Up 40% This Month, What Next?

French biotech ERYTECH Pharma S.A. (ERYP) has gained nearly 40% this month as the Company progresses with its lead product candidate Eryaspase, which is based on its proprietary ERYCAPS platform.

from RTT - Biotech https://ift.tt/39u8Kre
via IFTTT

Biotech Stocks Facing FDA Decision In January 2020

A total of 48 novel drugs and biologics received FDA approval in 2019. Let's take a look at the FDA calendar of January 2020.

from RTT - Biotech https://ift.tt/2ZBHjqK
via IFTTT

ARDS Turning Heads, AXSM's Momentum Continues, SVRA Abuzz, Jiankui Jailed

Today's Daily Dose brings you news about Aridis Pharma's collaboration with privately-held Mapp Biopharmaceutical; FDA approval for AZN/MRK's Lynparza for yet another indication; Axsome Therapeutics' continuing momentum; Sol-Gel's acne trial results; update on X4 Pharmaceuticals' Mavorixafor, and jail term for the Chinese scientist He Jiankui.

from RTT - Biotech https://ift.tt/36bXY6V
via IFTTT

Futures Pointing To Modestly Higher Open On Wall Street

The major U.S. index futures are currently pointing to a modestly higher opening on Monday following the lackluster performance seen in the previous session.

from RTT - Market Analysis https://ift.tt/2sxxyOj
via IFTTT

Dr. Reddy's Launches Generic Equivalent Of Nitropress Injection

Dr. Reddy's Laboratories Ltd. (RDY), an integrated pharmaceutical company, announced the launch of Sodium Nitroprusside Injection single-dose Vial, the therapeutic generic equivalent of Nitropress Injection, 50 mg/2mL vial. Sodium nitroprusside is indicated for the immediate reduction of blood pressure of patients in hypertensive crises. The company's FDA approved Sodium Nitroprusside Injection is available in the U.S. market in single-dose 50 mg/2 mL (25 mg/mL) vials.

from RTT - Biotech https://ift.tt/2u47kDz
via IFTTT

Cece's Ramen Noodles Recalled For Listeria Concerns

Veggie Noodle Co., LLC recalled its Cece's Veggie Co. brand Ramen noodles for fear of Listeria monocytogenes contamination. The recall involves all expiration dates of Cece's brand Fresh Veggie Ramen with Chicken Broth, which includes separately packaged egg - branded Peckish. The action was due to a recall by its egg supplier Almark Foods following recent Listeria illness outbreak.

from RTT - Biotech https://ift.tt/37vWDIv
via IFTTT

Avenue Therapeutics (ATXI) Hits All-time High, Up 56% So Far This Month

Shares of Avenue Therapeutics Inc. (ATXI), which closed at an all-time high of $9.22, have gained 56% so far this month.

from RTT - Biotech https://ift.tt/2MF3yqC
via IFTTT

What Awaits Mereo BioPharma (MREO) In 2020?

Mereo BioPharma Group plc (MREO) has gained over 160% in the last three trading days as it gears up for a couple of important clinical trial catalysts in the coming year.

from RTT - Biotech https://ift.tt/2QyLuj9
via IFTTT

Iterum Therapeutics: One Down, Two To Go

Iterum Therapeutics plc (ITRM) has two clinical trial catalysts to watch out for in the first quarter of 2020.

from RTT - Biotech https://ift.tt/2MEzICC
via IFTTT

U.S. Stocks May Extend Recent March To Record Highs

The major U.S. index futures are currently pointing to a higher opening on Friday, with stocks likely to see further upside after climbing to new record highs in the previous session.

from RTT - Market Analysis https://ift.tt/2ZrHLIh
via IFTTT

Ascendis Pharma (ASND) Keeps Growing...

Ascendis Pharma A/S (ASND) closed Thursday's trading at an all-time high of $136.83 as it gears up for some important clinical and regulatory catalysts in the coming months.

from RTT - Biotech https://ift.tt/35Z5GkM
via IFTTT

Verona Pharma (VRNA) Jumps 45% On Looming Trial Data

Shares of UK-based Verona Pharma plc (VRNA) soared nearly 45% on Thursday and added another 23% in extended trading as the Company awaits data from its phase IIb dose-ranging study evaluating the effect of nebulized Ensifentrine as an add-on to treatment with a long-acting bronchodilator in patients with moderate-to-severe chronic obstructive pulmonary disease.

from RTT - Biotech https://ift.tt/2Q1Pzgs
via IFTTT

Aprea Therapeutics (APRE) Marches Ahead, Up 130% In Nearly 3 Months

Aprea Therapeutics Inc. (APRE), which closed at a new high of $47.44 on Thursday, gaining nearly 20%, has more than doubled in value since its IPO on October 3, 2019.

from RTT - Biotech https://ift.tt/2tWnoar
via IFTTT

Oncolytics Biotech (ONCY) Hits New 52-week High, What's The Buzz?

Shares of Oncolytics Biotech Inc. (ONCY) jumped more than 50% to touch a 52-week high of $2.91 in intraday trading on Thursday, before closing at $2.82.

from RTT - Biotech https://ift.tt/2tMyIpl
via IFTTT

Markets May Continue To Benefit From Recent Upward Momentum

The major U.S. index futures are pointing to a modestly higher opening on Thursday as some traders return to their desks following the holiday on Wednesday.

from RTT - Market Analysis https://ift.tt/2rpYGOC
via IFTTT

Futures Pointing To Modest Strength On Wall Street

The major U.S. index futures are currently pointing to a modestly higher open on Tuesday, with stocks likely to extend a recent upward trend.

from RTT - Market Analysis https://ift.tt/2QfSOjr
via IFTTT

Mavidon Recalls Medical Devices For Burkholderia Cepacia Concerns

Mavidon is recalling all lots of medical device products manufactured at its facility with immediate effect due to contamination with Burkholderia cepacia, a multi-drug resistant pathogenic microorganism. The recall, with the knowledge of the FDA, involves LemonPrep, PediaPrep and Wave Prep 4-ounce tubes and single use cups, Cardio Prep and Collodions, Collodion removers.

from RTT - Biotech https://ift.tt/2QdOsJO
via IFTTT

FDA Approves New Treatment For Migraine In Adults

Adults suffering with acute and immediate attack of migraine now have a new treatment option with the approval of Ubrelvy (ubrogepant) by the U.S. Food and Drug Administration. Allergan USA, Inc.'s Ubrelvy tablets are approved to treat migraine with or without aura - a sensory phenomenon or visual disturbance, in adults. However, it is not indicated for the preventive treatment of migraine.

from RTT - Biotech https://ift.tt/2Mq5HGs
via IFTTT

BridgeBio Stock Up 60% So Far In Dec., IPO Lockup Period Expires Today

Shares of BridgeBio Pharma Inc. (BBIO) have gained 60% so far in December, as the Company gears up for some important events in the months ahead.

from RTT - Biotech https://ift.tt/2Zuoki5
via IFTTT

MBOT To Unveil 1st Disposable Robot For Endovascular Procedures, Stock Up 77%

Shares of medical device company Microbot Medical Inc. (MBOT) jumped more than 70% on Monday after the Company announced that it would be unveiling LIBERTY, the world's first fully disposable robotic system for use in neurovascular, cardiovascular and peripheral vascular procedures, on January 13, 2020, in San Francisco.

from RTT - Biotech https://ift.tt/34S2V3p
via IFTTT

Phathom Pharma Climbs 45% In 4 Days As Lead Drug Advances Into Phase III

Shares of Phathom Pharmaceuticals Inc. (PHAT) have gained an impressive 45% over the last four trading days, thanks to the progress in the development of its lead and sole drug Vonoprazan.

from RTT - Biotech https://ift.tt/2Sm9p83
via IFTTT

ACST On Watch, ITCI Jumps 250% On Trial Data, CVM Slumps, FDA Nod For AGN

Today's Daily Dose brings you news about FDA approvals of Allergan and Intra-Cellular Therapies; blockbuster deal signed between Roche and Sarepta; and positive phase III trial results of Progenics Pharmaceuticals, among others.

from RTT - Biotech https://ift.tt/2PP3Vkq
via IFTTT

Cobham’s US buyer vows to keep UK jobs and investment

Advent International also commits to British HQ, which employs about 1,700 staff

The new US owner of the UK defence company Cobham has pledged to keep jobs and investment in Britain as the government faces increasing criticism for allowing the £4bn takeover to go ahead.

The world-leading expert in air-to-air refuelling said its private-equity buyer, Advent International, had committed to maintaining a UK headquarters and to continue funding research and development at its Dorset offices. It has also vowed to keep using the company’s name, which references Sir Alan Cobham who founded the firm in 1934.

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/2QgyBKb

Positive Trade News May Generate Continued Buying Interest

The major U.S. index futures are currently pointing to a higher opening on Monday, with stocks likely to extend the upward trend seen in recent sessions.

from RTT - Market Analysis https://ift.tt/2PT5VIB
via IFTTT

Euro Tech Holdings Post Loss In H1 - Quick Facts

Euro Tech Holdings Co. Ltd. (CLWT) on Monday reported in its unaudited financial results for the six months ended June 30, 2019 a net loss of about $280,000 for the first-half of 2019, compared to net profit of about $878,000 in the prior-year period, which included a non-recurrent net gain on disposal of an affiliate of approximately $1.52 million.

from RTT - Earnings https://ift.tt/2EM0O6v
via IFTTT

Healthcare IPOs That Disappointed Investors In 2019

As we ready to step into 2020, it's time to take a look at some of the healthcare IPOs that failed to impress investors in 2019. As of now, 76 healthcare companies have made their debut on the bourses in 2019 versus more than 80 in the previous year and 50 in 2017.

from RTT - Biotech https://ift.tt/2sSYWWQ
via IFTTT

Eloxx Pharma Up 45% So Far In Dec., What Next?

Shares of Eloxx Pharmaceuticals Inc. (ELOX) are up over 45% so far this month as it awaits the phase II topline data of its lead drug candidate ELX-02 in nephropathic cystinosis.

from RTT - Biotech https://ift.tt/35PrTSb
via IFTTT

IVERIC Hits New 52-Week High, Stock Up 690% In 2 Months

Shares of IVERIC bio Inc. (ISEE), formerly Ophthotech Corp., have climbed more than 690% in just two months, thanks to the encouraging Zimura clinical trial results in geographic atrophy secondary to dry age-related macular degeneration.

from RTT - Biotech https://ift.tt/2sb9oc8
via IFTTT

Axsome Therapeutics' Awesome Journey From $3 To $100, What Next?

Shares of Axsome Therapeutics Inc. (AXSM) closed Friday's trading at $100.67, a gain of 115% in just five trading days. This is for the first time that the stock's closing price has hit the $100 mark. On Thursday, the stock had briefly touched an intraday high of $104.98, only to close at $95.30.

from RTT - Biotech https://ift.tt/2sMqA7U
via IFTTT

Upward Momentum May Lead To Continued Strength On Wall Street

The major U.S. index futures are currently pointing to a modestly higher opening on Friday, with stocks likely to see further upside after climbing to new record highs in the previous session.

from RTT - Market Analysis https://ift.tt/2MgJDhD
via IFTTT

FDA Grants Approval For Merck's Ebola Vaccine Ervebo - Quick Facts

The U.S. Food and Drug Administration announced Friday the approval of Merck & Co., Inc.'s (MRK) Ervebo, the first FDA-approved vaccine for the prevention of Ebola virus disease (EVD), caused by Zaire ebolavirus in individuals 18 years of age and older. Cases of EVD are very rare in the U.S.

from RTT - Biotech https://ift.tt/2s4i2sU
via IFTTT

Magic Mushroom Clears Safety Hurdle In Largest Controlled Study To Date

Recently, in a phase I placebo-controlled trial conducted by King's College London, Psilocybin was found to be well-tolerated when administered to healthy adult volunteers, and had no negative effects on cognitive and emotional functioning.

from RTT - Biotech https://ift.tt/2rWOhdM
via IFTTT

Quest Diagnostics - Growing & Gaining

Shares of Quest Diagnostics Incorporated (DGX), which touched a 52-week high of $108.95 in intraday trading yesterday, are up nearly 35 percent year-to-date.

from RTT - Biotech https://ift.tt/34GgTVQ
via IFTTT

PhaseBio Pharma Up 82% In 5 Days - What's The Buzz?

Shares of PhaseBio Pharmaceuticals Inc. (PHAS) have returned an impressive 82% over the last five trading days.

from RTT - Biotech https://ift.tt/2ttI895
via IFTTT

ENDRA Life Soars 35% As It Moves Towards Getting CE Mark For TAEUS Liver Device

ENDRA Life Sciences Inc. (NDRA) achieved a major step toward commercialization of TAEUS FLIP device on Thursday by submitting its Technical File for CE Mark review to its Notified Body.

from RTT - Biotech https://ift.tt/35HTsfY
via IFTTT

PLx Pharma Up 210% YTD, What Next?

Shares of PLx Pharma Inc. (PLXP) climbed more than 41% on Thursday, as the Company gears up to submit a supplemental new drug application to the FDA for Vazalore 81mg by the end of this year.

from RTT - Biotech https://ift.tt/35HSv7v
via IFTTT

FDA Nod For BHC, Third Rituxan Biosim In The Offing, CBIO Soars, NERV Depressed

Today's Daily Dose brings you news about FDA approval of Bausch Health's acne drug; licensing deal between Catalyst Biosciences and Biogen; disappointing MDD trial results of Minerva and Urogen's upcoming regulatory catalyst.

from RTT - Biotech https://ift.tt/2Ey0WGH
via IFTTT

Just Eat takeover battle heats up as rivals make new bids

Dutch takeaway company and offshoot of South African group up offers for food delivery firm

The battle for control of Just Eat has intensified after fresh rival bids for the UK food delivery business.

Takeaway.com of the Netherlands upped its all-share merger offer to a deal worth 916p a share. The offer, which would create one of the biggest food delivery groups in the world, values Just Eat at nearly £6.3bn, up from a previous bid in the summer that valued the company’s shares at 731p each.

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/34EvelE

Caution May Continue To Prevail On Wall Street

The major U.S. index futures are pointing to a roughly flat opening on Thursday, with stocks likely to extend the lackluster performance seen in the previous session.

from RTT - Market Analysis https://ift.tt/2PZ6ori
via IFTTT

Conagra Brands Trims FY20 Adj. EPS, Net Sales Outlook - Quick Facts

While reporting financial results for the second quarter on Thursday, Conagra Brands, Inc. (CAG) trimmed its adjusted earnings and net sales guidance range for the full-year 2020, primarily to reflect the divestiture of the DSD snacks business and the exit of its private label peanut butter business. The updated guidance includes the expected results from the Lender's business for the full fiscal year.

from RTT - Earnings https://ift.tt/2s5TsIj
via IFTTT

FactSet Affirms FY20 Outlook - Quick Facts

While reporting financial results for the first quarter and fiscal 2020 on Thursday, FactSet Research Systems Inc. (FDS) affirmed its earnings and revenue outlook for the full-year 2020.

from RTT - Earnings https://ift.tt/2PEuNDq
via IFTTT

Rite Aid Narrows FY20 Adj. EPS Outlook Range - Quick Facts

While reporting financial results for the third quarter on Thursday, drugstore chain Rite Aid Corp. (RAD) narrowed its earnings outlook for the full-year 2020, while maintaining annual revenue and same store sales guidance.

from RTT - Earnings https://ift.tt/2MbZ2zx
via IFTTT

Accenture Q1 Results Beat Estimates; Lifts Low End Of FY Outlook Range

Accenture Plc (ACN) on Thursday reported net income for the first quarter of $1.38 billion, a 6 percent increase from $1.29 billion in the same period last year. Earnings per share for the quarter rose to $2.09 from $1.96 in the prior-year period.

from RTT - Earnings https://ift.tt/2McsEwV
via IFTTT

Darden Reaffirms FY20 Outlook; Declares Qtly Dividend - Quick Facts

While reporting financial results for the second quarter on Thursday, Darden Restaurants, Inc. (DRI) again reaffirmed its financial outlook for the full-year 2020, which is a 53-week fiscal year. The outlook includes the impact of the additional week.

from RTT - Earnings https://ift.tt/2EvfE1b
via IFTTT

Mirum Pharma Surges 190% In 3 Days

Mirum Pharmaceuticals Inc. (MIRM), which topped the list of Biggest Percentage Price Gainers among healthcare stocks on Monday, topped the list again on Wednesday - gaining 44% to close at an all-time high of $23.76, before touching an intraday high $27.28.

from RTT - Biotech https://ift.tt/2Z7gOcK
via IFTTT

Futures Pointing To Another Uptick On Wall Street

The major U.S. index futures are pointing to a modestly higher opening on Wednesday, with stocks likely to show another uptick.

from RTT - Market Analysis https://ift.tt/35A7vnY
via IFTTT

General Mills Q2 Profit Beats Estimates, Organic Sales Up 1%; Affirms Outlook

General Mills (GIS) reported that its second-quarter adjusted earnings per share improved 11 percent year-on-year in constant currency to $0.95. On average, 17 analysts polled by Thomson Reuters expected the company to report profit per share of $0.88, for the quarter. Analysts' estimates typically exclude special items. Adjusted operating profit was $813 million, up 7 percent in constant currency, primarily driven by higher adjusted gross margin and lower consumer promotional expense, partially offset by higher media expense.

from RTT - Earnings https://ift.tt/2sIg6pS
via IFTTT

Peugeot and Fiat Chrysler agree terms of £38bn merger

Relief for PSA’s Vauxhall workers in Ellesmere Port as there will be no factory closures

Peugeot and Fiat Chrysler have agreed terms of a £38bn (€34bn) merger that will create the world’s fourth largest carmaker, the companies announced on Wednesday.

The two parent companies, PSA Group and Fiat Chrysler Automobiles, confirmed there will be no plant closures as part of €3.7bn in cost savings from the merger, a key concern for more than 1,000 workers at PSA’s Vauxhall factory in Ellesmere Port.

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/2EvPefw

Flexion Awaits FDA Word On Revised Zilretta Label

Shares of Flexion Therapeutics Inc. (FLXN) are down nearly 14 percent from their 52-week high of $21.39, recorded as recently as last week, and trade around $18.

from RTT - Biotech https://ift.tt/2Py3R8I
via IFTTT

Top Gainers: VIE To Face FDA In June, NLTX Up 65% In Dec., Be AWARE Of ONCY

The following are some of today's top gainers in the healthcare sector.

from RTT - Biotech https://ift.tt/2M749kD
via IFTTT

Traders Looking For Next Catalyst To Drive The Markets

The major U.S. index futures are currently pointing to a roughly flat open on Tuesday, with stocks likely to show a lack of direction after climbing to record highs in the previous session.

from RTT - Market Analysis https://ift.tt/2PTSqab
via IFTTT

Jabil Boosts FY20 Core EPS Outlook: Guides Q2 In Line With View - Quick Facts

While reporting preliminary, unaudited financial results for its first quarter of fiscal 2020 on Tuesday, Jabil, Inc. (JBL) provided earnings and revenue guidance for the second quarter in line with analysts' estimates. The company also raised its core earnings outlook for the full-year 2020.

from RTT - Earnings https://ift.tt/36NXIL1
via IFTTT

Worthington Industries Q2 Results Top Estimates - Quick Facts

Worthington Industries, Inc. (WOR) reported Tuesday that net earnings for the second quarter of fiscal 2020 grew to $52.1 million or $0.93 per share from $34.0 million or $0.57 per share in the prior-year quarter.

from RTT - Earnings https://ift.tt/38M2Jpf
via IFTTT

Drugs That Missed Key Goals In Phase III Trials

In this article, we present some of the phase III clinical trial failures that made major news headlines in 2019. These were compounds on which companies had bet big, with patients and the medical community having had high hopes.

from RTT - Biotech https://ift.tt/2szfrHp
via IFTTT

Top Gainers: CLSD Making A Second Try, RLMD Abuzz, Busy Year Ahead For BTAI

The following are some of the stocks that gained the most in the healthcare sector on Monday.

from RTT - Biotech https://ift.tt/2RWJUtw
via IFTTT

AXSM Again Proves It Is Awesome, MIRM Leaps To $22, WVE Doesn't Go The Distance

Today's Daily Dose brings you news about Akero's NASH study update; Axsome Therapeutics' major depressive disorder trial results; CEL-SCI's near-term catalyst; BioMarin's promising results of achondroplasia drug candidate; Wave Life Sciences decision to discontinue the development of DMD drug candidate and more.

from RTT - Biotech https://ift.tt/2rJBQSx
via IFTTT

Amneal Pharma (AMRX) Focusing On 2020 & Beyond

Shares of Amneal Pharmaceuticals Inc. (AMRX) have nearly doubled over the last 28 trading days and trade around $5.40.

from RTT - Biotech https://ift.tt/2PUbN2X
via IFTTT

Did Stryker (SYK) Catch Your Eye?

Shares of Stryker Corp. (SYK), a medical technology company, are up in pre-market trading today.

from RTT - Biotech https://ift.tt/2EkCJ6w
via IFTTT

Positive Sentiment May Lead To Continued Strength On Wall Street

The major U.S. index futures are currently pointing to a higher opening on Monday, with stocks likely to extend the advance seen last week.

from RTT - Market Analysis https://ift.tt/38JnOka
via IFTTT

Will These Pharma Stocks Soar Or Swoon This Month? (ACER, ACST, ADMS, SLGL)

Listed below are some of the pharma companies whose phase III trial results might be reported this month.

from RTT - Biotech https://ift.tt/2tnqdkv
via IFTTT

British Steel bid still on, insists Chinese firm Jingye

Jitters in Whitehall grow over any further delay with government spending £1m a day to keep business alive

The Chinese firm poised to buy British Steel has denied the deal is in danger of collapse, amid concern that any further delay in the already lengthy sale process will make the business less attractive to alternative buyers.

Jingye, an industrial giant founded by a former Communist party official, agreed to buy British Steel in early November after an earlier round of talks with the pension fund of the Turkish military broke down.

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/2PMyc2b

Are These Biotech Companies Buyout Candidates? Deal Or No Deal?

2019 saw more than 25 acquisition deals being executed in the biotech sector, of which 14 were billion-dollar deals. Bristol-Myers Squibb (BMY) acquiring Celgene for $74 billion in January remains the most expensive acquisition of this year.

from RTT - Biotech https://ift.tt/2PmA2HX
via IFTTT

Futures Pointing To Higher Open Ahead Of Chinese Press Conference

The major U.S. index futures are currently pointing to a higher opening on Friday following the strong upward move seen in the previous session.

from RTT - Market Analysis https://ift.tt/2EgNBT2
via IFTTT

First Generic Version Of NuvaRing Gets FDA Nod, ONCT On Watch, SRPT Surges

Today's Daily Dose brings you news about the sweet surprise for Sarepta; spike in Amneal Pharma's stock price; Oncternal Therapeutics' breast cancer trial results and Centene's 2020 outlook.

from RTT - Biotech https://ift.tt/35hpqj9
via IFTTT

Home Depot Blames Opioid Crisis For Recent Rise In Store Thefts

Home Depot has blamed the nation's opioid crisis for the recent surge in theft at its stores, reports said. The home improvement retailer made the claim at an analyst and investor conference on Wednesday saying it expects the theft, which retailers call shrink, to narrow its operating margin for the next year. The opioid crisis in the U.S. is growing at an alarming rate.

from RTT - Earnings https://ift.tt/34dtq2W
via IFTTT

Stock Alert: What's The Buzz About MEDNAX (MD)?

Shares of MEDNAX Inc. (MD) have climbed over 5% in the last 4 trading days.

from RTT - Biotech https://ift.tt/38pTTgO
via IFTTT

Lingering Uncertainty About Trade Deal May Weigh On Wall Street

The major U.S. index futures are pointing to a modestly lower opening on Thursday following the uptick seen in the previous session.

from RTT - Market Analysis https://ift.tt/2rEjnXi
via IFTTT

Healthcare IPOs That Delivered Solid Returns In 2019

2020 will be upon us soon. It's time to take stock of some of the US healthcare IPOs that rewarded investors in 2019.

from RTT - Biotech https://ift.tt/2EeKVFa
via IFTTT

GILD's KTE-X19 To Face FDA, NTEC Drops As NVS Walks Away, KZIA On Watch

Today's Daily Dose brings you news about Puma Biotech's SUMMIT basket trial results; TransEnterix' reverse stock split; Seattle Genetics' pivotal HER2CLIMB study and the latest update on Intec/Novartis deal.

from RTT - Biotech https://ift.tt/2qFycs2
via IFTTT

Looming Fed Announcement May Lead To Choppy Trading On Wall Street

The major U.S. index futures are pointing to a mixed opening on Wednesday, with stocks likely to extend the choppy trading seen in the previous session.

from RTT - Market Analysis https://ift.tt/2t91PTB
via IFTTT

American Eagle Guides Q4 Adj. EPS Below View - Quick Facts

While reporting financial results for the third quarter on Wednesday, specialty retailer American Eagle Outfitters, Inc. (AEO) provided earnings and comparable sales growth guidance for the fourth quarter.

from RTT - Earnings https://ift.tt/36u5gmh
via IFTTT

Children's Place Slashes FY19 Outlook, Declares Dividend - Quick Facts

While reporting financial results for the third quarter on Wednesday, children's specialty apparel retailer The Children's Place, Inc. (PLCE) provided adjusted earnings and net sales guidance for the fourth quarter and slashed outlook for the full-year 2019.

from RTT - Earnings https://ift.tt/2YNsT6N
via IFTTT

JetBlue Airways November Traffic, Capacity Rise; Load Factor Declines

JetBlue Airways Corp. (JBLU) reported Wednesday its preliminary traffic results for November 2019. Traffic in November increased 3.7 percent from the year-ago period, on a capacity increase of 7.1 percent.

from RTT - Earnings https://ift.tt/2Pyu9q2
via IFTTT

United Natural Foods Reaffirms FY20 Outlook - Quick Facts

While reporting financial results for the first quarter on Wednesday, United Natural Foods, Inc. (UNFI) reaffirmed its adjusted earnings and net sales guidance for the full year 2020.

from RTT - Earnings https://ift.tt/38qFNMc
via IFTTT

Photronics Guides Q1 EPS, Revenues Above Estimates - Quick Facts

While reporting financial results for the fourth quarter on Wednesday, Photronics, Inc. (PLAB) provided earnings and revenue guidance for the first quarter of fiscal 2020, above analysts' estimates.

from RTT - Earnings https://ift.tt/2PDdBNF
via IFTTT

GRTS To Report GRANITE, SLATE Early Phase I Immunogenicity Data On Dec.12

Shares of Gritstone Oncology Inc. (GRTS), a clinical-stage biotechnology company, have rallied 26 percent so far this month in the run-up to the presentation at the European Society for Medical Oncology's Immuno-Oncology Congress (ESMO-IO) on December 12, 2019.

from RTT - Biotech https://ift.tt/2YACYDM
via IFTTT

FDA Panel Says No To CORV, ITRM For Sure Has Disappointed, ELOX, XERS On Watch

Today's Daily Dose brings you news about the FDA panel's vote on Correvio Pharma's anti-arrhythmic drug Brinavess; the near-term catalyst of Eloxx Pharma; the phase III trial results of Iterum's Sulopenem in the treatment of complicated intra-abdominal infections, and Xeris Pharma's phase II study results of ready-to-use (RTU) glucagon.

from RTT - Biotech https://ift.tt/38lrJ6N
via IFTTT

Report Of Tariff Delay May Lead To Initial Strength On Wall Street

The major U.S. index futures have recently turned positive and are currently pointing to a higher open for the markets on Tuesday.

from RTT - Market Analysis https://ift.tt/2sZsP7P
via IFTTT

QTS Realty Trust - So Far, So Good

Shares of QTS Realty Trust Inc. (QTS), a US-based data center operator, are up 48 percent year-to-date.

from RTT - Earnings https://ift.tt/2P54Htc
via IFTTT

APTO On The Move, PLX To Effect Reverse Split, SCYX Plunges

Today's Daily Dose brings you news about Aurinia Pharma's secondary offering; Aptose Biosciences' early clinical data of CG-806 and APTO-253; the proposed reverse stock split of Protalix BioTherapeutics and Gilead's path forward for KTE-X19 in the treatment for relapsed or refractory mantle cell lymphoma.

from RTT - Biotech https://ift.tt/33ZRkPe
via IFTTT

Top Gainers: THOR Acquired, FTSV Up On Magrolimab Data, Investors Believe FATE

The following are some of today's top gainers in the healthcare sector.

from RTT - Biotech https://ift.tt/2Yy0tNF
via IFTTT

Had You Invested In ArQule (ARQL) In June,...

Shares of ArQule Inc. (ARQL) are currently up over 100 percent, trading at $19.66, as the Company is all set to be acquired by Merck Inc. (MRK).

from RTT - Biotech https://ift.tt/2LG01rI
via IFTTT

Futures Pointing To Modestly Lower Open On Wall Street

The major U.S. index futures are currently pointing to a modestly lower opening on Monday following the upward trend seen over the past few sessions.

from RTT - Market Analysis https://ift.tt/2YyzUb7
via IFTTT

Globus Medical's (GMED) Got A Spine...

Shares of Globus Medical Inc. (GMED) closed at an all-time high of $57.18 on Friday (Dec.6), and are up 32 percent year-to-date.

from RTT - Biotech https://ift.tt/2qxri8c
via IFTTT

At The ASH 2019 Annual Meeting: AXLA, CBMG, SRRA, EPZM, STOK...

The following are some of the companies that presented new/updated trial data of their investigational drug candidates at the 61st Annual Meeting of the American Society of Hematology (ASH) on Saturday.

from RTT - Biotech https://ift.tt/33X2apf
via IFTTT

What Awaits Obseva (OBSV) On Monday?

Obseva SA (OBSV), a specialty biopharmaceutical company operating in the field of women's health and reproductive medicine, awaits a key catalyst on Monday.

from RTT - Biotech https://ift.tt/2sVYoQd
via IFTTT

Stronger Than Expected Jobs Data May Spark Early Buying Interest

The major U.S. index futures are currently pointing to a higher opening on Friday following the lackluster performance seen in the previous session.

from RTT - Market Analysis https://ift.tt/2RBD3G3
via IFTTT

Genesco Raises Full Year Outlook; Records 37% Increase In Q3 Adj. EPS

Genesco Inc. (GCO) announced, for fiscal 2020, the company now expects adjusted earnings per share from continuing operations in the range of $4.10 to $4.40 with an expectation that earnings per share for the year will be near the mid-point of the range. This an increase from the previous guidance range of $3.80 to $4.20. Comparable sales are anticipated to be up 2 percent to 3 percent, for the fiscal year. Analysts polled by Thomson Reuters expect the company to report profit per share of $4.05. Analysts' estimates typically exclude special items.

from RTT - Earnings https://ift.tt/2rbPqhc
via IFTTT

DOMO, DOCU, ULTA, ZUMZ On The Rise Following Earnings Results

We are featuring some stocks which climbed after-hours Thursday following the companies reported encouraging earnings results

from RTT - Earnings https://ift.tt/33WUqDo
via IFTTT

Hovnanian Enterprises Revenue Rises 16%, Stock Up

Shares of Hovnanian Enterprises Inc. (HOV), are on the run, after the homebuilder reported a 16% revenue growth and a 16.7% increase in consolidated deliveries for the fourth quarter of fiscal 2019. However, the Company incurred a loss in the fiscal fourth quarter compared to a profit in the year-ago quarter.

from RTT - Earnings https://ift.tt/2Lqs3qK
via IFTTT

Express Stock Up Over 20%

Shares of Express Inc. (EXPR), a fashion apparel retailer, are currently up over 20%, following better-than-expected topline and revenue for the third quarter, and upbeat earnings outlook for the fourth quarter.

from RTT - Earnings https://ift.tt/2rk7cyB
via IFTTT

RH Hits New High On Strong Q3 Results, Upbeat Outlook

Shares of luxury furnishing retailer RH, formerly Restoration Hardware, touched a new high of $225, and are currently trading at $$223.48, thanks to record third quarter results and upbeat fiscal 2019 guidance.

from RTT - Earnings https://ift.tt/2LnWMET
via IFTTT

Aston Martin shares accelerate on talk of bid by F1 billionaire

Lawrence Stroll, owner of Formula One team Racing point, seeking large stake

Shares in Aston Martin have surged on reports that the billionaire owner of a Formula One racing team is preparing to bid for a significant stake in the luxury carmaker.

Lawrence Stroll, the owner of Racing Point, is leading a consortium that is considering a stake in the British firm, according to Autocar.

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/2rhRXGy

Kroger Confirms FY19, FY20 Outlook - Quick Facts

While reporting financial results for the third quarter on Thursday, Kroger Co. (KR) confirmed adjusted earnings and identical sales growth guidance for the full-year 2019 and 2020.

from RTT - Earnings https://ift.tt/2rVqfzk
via IFTTT

Upward Momentum May Make Resurgence On Wall Street

The major U.S. index futures are pointing to a higher opening on Thursday, with stocks likely to add to the gains posted in the previous session.

from RTT - Market Analysis https://ift.tt/38bipCo
via IFTTT

Patterson Boosts FY20 Adj. EPS Outlook - Quick Facts

While reporting financial results for the second quarter on Thursday, Patterson Companies Inc. (PDCO) raised its adjusted earnings guidance for the full-year 2020.

from RTT - Earnings https://ift.tt/2DMXQxZ
via IFTTT

Dollar General Boosts FY19 Outlook - Quick Facts

While reporting financial results for the third quarter on Thursday, Dollar General Corp. (DG) raised its earnings, adjusted earnings and sales growth guidance for the full-year 2019, based on the performance through the first three quarters of 2019 and outlook for the fourth quarter.

from RTT - Earnings https://ift.tt/2YjCku6
via IFTTT

Bausch Health (BHC) Hits A New High, What Next?

Shares of Bausch Health Companies Inc. (BHC) (BHC.TO), which are up 55 percent year-to-date, closed at an all-time high of $28.68 yesterday.

from RTT - Biotech https://ift.tt/2rivQzD
via IFTTT

AUPH Soars On Lupus Trial Results, ACAD On Watch, ALNA Trims Workforce

Today's Daily Dose brings you news about the layoff in Allena Pharma; the positive phase III trial results of Aurinia Pharma's lupus drug; stock offerings of Millendo Therapeutics and Relmada Therapeutics.

from RTT - Biotech https://ift.tt/33TqKXU
via IFTTT

Today's Top Gainers: PTGX Bounces Back, ALLK Abuzz, AVXL On The Move...

The following are some of today's top gainers in the healthcare sector.

from RTT - Biotech https://ift.tt/386ierV
via IFTTT

Upbeat Report On Trade Talks May Inspire Bargain Hunting

The major U.S. index futures are pointing to a higher opening on Wednesday following the notable pullback seen over the course of the three previous sessions.

from RTT - Market Analysis https://ift.tt/2DH6ePI
via IFTTT

Campbell Soup Backs FY20 Adj. EPS Outlook - Quick Facts

While reporting financial results for the first quarter of fiscal 2020 on Wednesday, Campbell Soup Co. (CPB) maintained its adjusted earnings and organic sales growth guidance for the full-year 2020, but lowered net sales growth guidance to reflect the impact of the sale of European Chips Business.

from RTT - Earnings https://ift.tt/35XHI8Q
via IFTTT

National Bank Boosts Qtly Dividend 4% - Quick Facts

National Bank of Canada (NA.TO) announced Wednesday that it's Board of Directors a 4 percent higher quarterly dividend of $0.71 per common share for the quarter ending January 31, 2020. This dividend is payable on February 1, 2020 to common shareholders of record on December 30, 2019.

from RTT - Earnings https://ift.tt/363kgqZ
via IFTTT

Healthcare Stocks That Plunged To New Lows (PTGX, TRPX, MTP...)

We are featuring some stocks whose value dropped to new low year-to-date.

from RTT - Biotech https://ift.tt/3847dHE
via IFTTT

ARDX Jumps On PHREEDOM Data, AXSM Is Awesome, CARA On Watch

Today's Daily Dose brings you news about Ardelyx' PHREEDOM trial results; narcolepsy trial results of Axsome; TRANSCEND trial results of Protagonist Therapeutics and FDA approval of Roche's (RHHBY.OB) Tecentriq for yet another indication.

from RTT - Biotech https://ift.tt/2ONy4jw
via IFTTT

Today's Top Gainers: OTLK Well Visioned, BCEL On The Move, ITRM On Watch

The following are some of today's top gainers in the healthcare sector.

from RTT - Biotech https://ift.tt/2RecVkd
via IFTTT

The IFS raises a far better question on Labour's renationalisation plans | Nils Pratley

Key issue is how well assets such as railways and energy would run under public ownership, not the cost

The Institute for Fiscal Studies is asking the right question about Labour’s nationalisation plans. The key issue is how well the assets would be run under public ownership. What is the party hoping to achieve that could not be done via smarter regulation?

This part of the debate has been obscured by endless quarrels over how much it would cost to nationalise rail, mail, water, energy and BT Openreach. On the cost score, the IFS report merely offered a factual two-part answer, one of which was necessarily imprecise.

Related: IFS warns Labour renationalisation may delay low-carbon economy

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/2LjRGtD

Trump Comments About Trade Deal May Spark Initial Sell-Off On Wall Street

The major U.S. index futures are pointing to a sharply lower opening on Tuesday, with stocks likely to extend the pullback seen over the two previous sessions.

from RTT - Market Analysis https://ift.tt/37UwWCa
via IFTTT

Bank Of Montreal Boosts Qtly Dividend 6% - Quick Facts

Bank of Montreal (BMO, BMO.TO) announced Tuesday that its Board of Directors declared a 6 percent higher quarterly dividend of C$1.06 per share on paid-up common shares of Bank of Montreal for the first quarter of fiscal year 2020. The dividend is payable on February 26, 2020, to shareholders of record on February 3, 2020.

from RTT - Earnings https://ift.tt/34HZrkI
via IFTTT

Healthcare Stocks That Hit New Highs (XENE, AQST, DRNA...)

The following are some of the healthcare stocks that hit a new high yesterday.

from RTT - Biotech https://ift.tt/33Kmz0y
via IFTTT

AGTC Awaits Data In Jan., EVFM Walks The Talk, Today's A Big Day For ALDX

Today's Daily Dose brings you news about Applied Genetic Technologies' near-term catalysts; the acquisition of Audentes by Astellas; Aldeyra's immediate catalyst; Evofem's AMPREVENCE study results and Lexicon Pharma's setback.

from RTT - Biotech https://ift.tt/2Rkrl2p
via IFTTT

KOD Dazzles, GLMD On Watch, DRIO Turns Heads.

The following are some of today's top gainers in the healthcare sector.

from RTT - Biotech https://ift.tt/2OKJXXE
via IFTTT

Futures Pointing To Initial Strength On Wall Street

The major U.S. index futures are currently pointing to a modestly higher opening on Monday following the pullback seen in the previous session.

from RTT - Market Analysis https://ift.tt/2P2z3LC
via IFTTT

Mylan, Biocon Announce US Launch Of Trastuzumab Biosimilar Ogivri - Quick Facts

Pharmaceutical company Mylan N.V. (MYL) and India-based Biocon Ltd. announced Monday the U.S. launch of Ogivri (trastuzumab-dkst), a biosimilar to Herceptin (trastuzumab). The product is co-developed by Mylan and Biocon.

from RTT - Biotech https://ift.tt/34HeIlI
via IFTTT

Sirona Biochem's Skin Lightening Agent Found To Be Safe At Higher Dose

Sirona Biochem Corp. (SBM.V) (SRBCF.OB) announced that its investigative skin lightening compound TFC-1067 has been successfully completed a toxicology test for an increased dose of 0.4%, in preparation for the new clinical study.

from RTT - Biotech https://ift.tt/2P24u8Q
via IFTTT

Kadmon Holdings' (KDMN) Rocking, Will The Rally Continue?

Shares of Kadmon Holdings Inc. (KDMN) have gained an impressive 53% over the last 1 month.

from RTT - Biotech https://ift.tt/35XyYQl
via IFTTT

Biotech Stocks Facing FDA Decision In December 2019

As we begin the final month of the year, it's time to take a look at the drug candidates lined up at the FDA altar awaiting the federal agency's decision.

from RTT - Biotech https://ift.tt/2syJD5r
via IFTTT